Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.64 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.50 |
| ▸ | PCNA | P12004 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 7/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | BAX | Q07812 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | THRA | P10827 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2349794 | 0.91 | FFAR1 (0.58) | FFAR1HRH1CAMK2APCNAFFAR4 | |
| SCHEMBL3503975 | 0.90 | FFAR1 (0.67) | FFAR1HRH1CAMK2AFFAR4SRD5A2 | |
| SCHEMBL2353783 | 0.84 | CAMK2A (0.69) | FFAR1HRH1CAMK2AFFAR4LTA4H | |
| SCHEMBL25936968 | 0.84 | FFAR1 (0.56) | FFAR1HRH1FFAR4 | |
| SCHEMBL3424980 | 0.83 | CAMK2A (0.73) | FFAR1CAMK2APCNAFFAR4POLB | |
| SCHEMBL8495825 | 0.80 | HRH1 (0.61) | FFAR1HRH1CAMK2AFFAR4POLB | |
| SCHEMBL3809518 | 0.79 | FFAR1 (0.58) | FFAR1HRH1CAMK2AFFAR4SRD5A2 | |
| SCHEMBL6936340 | 0.79 | HRH1 (0.50) | FFAR1HRH1LTA4HNR1H2BAX | |
| SCHEMBL1745598 | 0.79 | FFAR1 (1.00) | FFAR1FFAR4 | |
| SCHEMBL1666512 | 0.79 | SLC1A5 (0.57) | FFAR1HRH1PCNALTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8476399-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2013-07-02 | — | — | US | disclosed |
| US-20130085238-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2013-04-04 | — | — | US | disclosed |
| US-8252887-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-08-28 | — | — | US | disclosed |
| US-20100234555-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY (US) | 2010-09-16 | — | — | US | disclosed |
| WO-2010042918-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2010-04-15 | — | — | WO | disclosed |
| CN-100422129-C | Production process of optically pure 2- (4-hydroxyphenoxy) - propionic acid compounds | SYNGENTA LTD (GB) | 2008-10-01 | — | — | CN | disclosed |
| CN-1852884-A | Preparation method of optically pure 2- (4-hydroxyphenoxy) -propionic acid compound | SYNGENTA LTD (GB) | 2006-10-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234555-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | ECPAS, PTGIR, RXFP1 | FFAR1 827/4885HRH1 920/4885CAMK2A 3861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.